Current and historical daily PE Ratio for Qiagen NV (
) from 1997 to Apr 28 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Qiagen NV stock (XTER:QIA) PE ratio as of Apr 28 2024 is 27.29.
More Details
Qiagen NV (XTER:QIA) PE Ratio (TTM) Chart
Qiagen NV (XTER:QIA) PE Ratio (TTM) Historical Data
View and export this data going back to 1997. Start your Free Trial
Total 1260
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Qiagen NV PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-04-28 | 27.4 | 2024-02-22 | 28.2 |
| 2024-04-26 | 27.4 | 2024-02-21 | 27.8 |
| 2024-04-25 | 26.8 | 2024-02-20 | 27.9 |
| 2024-04-24 | 27.3 | 2024-02-19 | 28.0 |
| 2024-04-23 | 27.5 | 2024-02-16 | 28.3 |
| 2024-04-22 | 27.2 | 2024-02-15 | 28.0 |
| 2024-04-19 | 26.5 | 2024-02-14 | 28.1 |
| 2024-04-18 | 26.2 | 2024-02-13 | 28.4 |
| 2024-04-17 | 26.2 | 2024-02-12 | 28.8 |
| 2024-04-16 | 26.1 | 2024-02-09 | 28.7 |
| 2024-04-15 | 26.5 | 2024-02-08 | 28.7 |
| 2024-04-12 | 27.0 | 2024-02-07 | 28.7 |
| 2024-04-11 | 27.1 | 2024-02-06 | 29.4 |
| 2024-04-10 | 27.3 | 2024-02-05 | 28.0 |
| 2024-04-09 | 27.1 | 2024-02-02 | 28.2 |
| 2024-04-08 | 26.9 | 2024-02-01 | 28.4 |
| 2024-04-05 | 26.7 | 2024-01-31 | 28.6 |
| 2024-04-04 | 27.0 | 2024-01-30 | 28.4 |
| 2024-04-03 | 27.4 | 2024-01-29 | 29.6 |
| 2024-04-02 | 27.8 | 2024-01-26 | 29.9 |
| 2024-03-28 | 28.0 | 2024-01-25 | 29.6 |
| 2024-03-27 | 27.8 | 2024-01-24 | 29.5 |
| 2024-03-26 | 27.6 | 2024-01-23 | 29.8 |
| 2024-03-25 | 28.2 | 2024-01-22 | 30.2 |
| 2024-03-22 | 28.3 | 2024-01-19 | 30.1 |
| 2024-03-21 | 28.6 | 2024-01-18 | 29.9 |
| 2024-03-20 | 28.5 | 2024-01-17 | 30.1 |
| 2024-03-19 | 28.8 | 2024-01-16 | 30.4 |
| 2024-03-18 | 28.7 | 2024-01-15 | 29.6 |
| 2024-03-15 | 28.4 | 2024-01-12 | 29.9 |
| 2024-03-14 | 28.4 | 2024-01-11 | 29.6 |
| 2024-03-13 | 28.7 | 2024-01-10 | 29.7 |
| 2024-03-12 | 29.0 | 2024-01-09 | 30.4 |
| 2024-03-11 | 29.2 | 2024-01-08 | 30.0 |
| 2024-03-08 | 28.9 | 2024-01-05 | 29.2 |
| 2024-03-07 | 28.8 | 2024-01-04 | 28.9 |
| 2024-03-06 | 28.9 | 2024-01-03 | 28.7 |
| 2024-03-05 | 28.9 | 2024-01-02 | 29.0 |
| 2024-03-04 | 28.6 | 2024-01-01 | 28.7 |
| 2024-03-01 | 28.2 | 2023-12-29 | 28.7 |
| 2024-02-29 | 28.0 | 2023-12-28 | 28.6 |
| 2024-02-28 | 28.1 | 2023-12-27 | 28.9 |
| 2024-02-27 | 28.3 | 2023-12-26 | 29.0 |
| 2024-02-26 | 28.4 | 2023-12-25 | 29.0 |
| 2024-02-23 | 28.4 | 2023-12-22 | 29.0 |
Qiagen NV (XTER:QIA) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Qiagen NV
NAICS : 541720
SIC : 8733
ISIN : NL0015001WM6
Share Class Description:
XTER:QIA: Ordinary SharesDescription
Qiagen NV offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (over 45% of 2022 sales), followed by EMEA (nearly 35%), and Asia-Pacific (nearly 20%).
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers